Physostigmine: Effects on cognition and affect in normal subjects
- 62 Downloads
Physostigmine was given intravenously to a total dose of 3 mg to 13 subjects; a placebo of 0.25 N saline was given intravenously to 10 other subjects; both groups received 1 mg of methscopolamine bromide subcutaneously preceding the intravenous infusions. A “physostigmine syndrome” consisting of decreased speech, slowed thoughts, mild sedation, expressionless faces, nausea, and decreased spontaneous activity was evident following doses of 1.5 to 2.0 mg of physostigmine. The capacity of short-term memory (STM) as measured by digit span tasks was significantly less for the subjects who received physostigmine than for the subjects who received placebo. No difference was observed between the two groups on tasks of consolidation from STM to long-term memory (LTM).
Subiects who received physostigmine did not significantly differ from subjects who received placebo in their mood. However, two subjects in the physostigmine group, and no subjects in the saline group became tearful and depressed.
Key wordsPhysostigmine Short-term memory Long-term memory Depression Mania
Unable to display preview. Download preview PDF.
- Atkinson, R. C., Shiffrin, R. M.: The control of short-term memory. Sci. Amer. 225, 82–90 (1971)Google Scholar
- Bunney, W. E., Jr., Hamburg, D. A.: Methods for reliable longitudinal observation of behavior. Arch. gen. Psychiat. 9, 280–294 (1963)Google Scholar
- Carroll, B. J., Frazer, A., Schless, A., Mendels, J.: Cholinergic reversal of manic symptoms. Lancet 1973I, 427–428Google Scholar
- Dawson, R. S., McGaugh, J. L.: The physiological basis of memory, J. A. Deutsch, ed., pp. 77–111. New York: Academic Press 1973Google Scholar
- Deutsch, J. A.: The cholinergic synapse and the site of memory. Science 174, 788–794 (1971)Google Scholar
- Deutsch, J. A.: The physiological basis of memory, J. A. Deutsch, ed., pp. 59–78. New York: Academic Press 1973Google Scholar
- Drachman, D. A., Leavitt, J.: Human memory and the cholinergic system. Arch. Neurol. (Chic.) 30, 113–122 (1974)Google Scholar
- Gershon, S., Shaw, F. H.: Psychiatric sequalae of chronic exposure to organo-phosphorus insecticides. Lancet 1961I, 1371–1374Google Scholar
- Gilbert, J. G., Levee, R. F., Catalaro, F. C.: A preliminary report on a new memory scale. Percept. Motor Skills 27, 277–278 (1968)Google Scholar
- Isaacs, B., Kennle, A. T.: The set test as an aid to the detection of dementia in old people. Brit. J. Psychol. 123, 467–470 (1973)Google Scholar
- Janowsky, D. S., El-Yousef, M. K., Davis, J. M.: Parasympathetic suppression of manic symptoms by physostigmine. Arch. gen. Psychiat. 28, 542–547 (1973)Google Scholar
- Kesner, R.: A neural system analysis of memory storage and retrieval. Psychol. Bull. 80, 177–203 (1973)Google Scholar
- Reitan, R. M.: Validity of the trail making test as an indicator of organic brain damage. Percept. Motor Skills 46, 339–346 (1958)Google Scholar
- Sianska, J., Vojtechwsky, M., Votova, Z.: The influence of physostigmine on individual phases of learning in man. Activ. nerv. sup. (Praha) 14, 110 (1972)Google Scholar
- Sternberg, D. E., Jarvik, M. E.: Memory functions in depression. Arch. gen. Psychiat. 33, 219–224 (1976)Google Scholar
- Tulving, E., Donaldson, W.: Organization of memory. New York: Academic Press 1972Google Scholar
- Wechsler, D.: A standardized memory scale for clinical use. J. Psychol. 19, 87–95 (1945)Google Scholar
- Whitehead, A.: Verbal learning and memory in elderly depressives. Brit. J. Psychol. 123, 203–208 (1973)Google Scholar